Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125227671 | 12522767 | 1 | I | 20100330 | 20160329 | 20160701 | 20160701 | PER | ZA-FRI-1000084412 | FOREST | 83.90 | YR | F | Y | 45.00000 | KG | 20160701 | OT | DK | ZA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125227671 | 12522767 | 1 | PS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG | Y | 21323 | 10 | MG | TABLET | QD | |||||
125227671 | 12522767 | 2 | SS | ESCITALOPRAM | ESCITALOPRAM OXALATE | 1 | Y | 21323 | |||||||||||
125227671 | 12522767 | 3 | SS | Rasagiline | RASAGILINE | 1 | Oral | 1 MG | Y | 0 | 1 | MG | TABLET | QD | |||||
125227671 | 12522767 | 4 | SS | PARACETAMOL W/TRAMADOL HYDROCHLORIDE | ACETAMINOPHENTRAMADOL HYDROCHLORIDE | 1 | Oral | 18.75 MG | Y | 0 | 37.5 | MG | TABLET | ||||||
125227671 | 12522767 | 5 | SS | FENTANYL. | FENTANYL | 1 | Transdermal | 12.5 MICROGRAM PER HOUR | 0 | SOLUTION | |||||||||
125227671 | 12522767 | 6 | SS | STALEVO | CARBIDOPAENTACAPONELEVODOPA | 1 | Oral | 500 MG | Y | 0 | 100 | MG | TABLET | ||||||
125227671 | 12522767 | 7 | C | CELECOXIB. | CELECOXIB | 1 | Oral | 100 MG | 0 | 100 | MG | TABLET | QD | ||||||
125227671 | 12522767 | 8 | C | ZOPICLONE | ZOPICLONE | 1 | Oral | NOCTE DAY | 0 | 7.5 | MG | TABLET | |||||||
125227671 | 12522767 | 9 | C | SINEMET | CARBIDOPALEVODOPA | 1 | Oral | 50/200 MG OD FOR YEARS?NOCTE DAY | 0 | TABLET | |||||||||
125227671 | 12522767 | 10 | C | ERGOCALCIFEROL. | ERGOCALCIFEROL | 1 | Oral | MONDAY, WEDNESDAY AND FRIDAY | 0 | TABLET | TIW | ||||||||
125227671 | 12522767 | 11 | C | OCUVITE | VITAMINS | 1 | Unknown | 0 | TABLET |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125227671 | 12522767 | 1 | Depression |
125227671 | 12522767 | 2 | Anxiety |
125227671 | 12522767 | 3 | Parkinson's disease |
125227671 | 12522767 | 4 | Osteoarthritis |
125227671 | 12522767 | 5 | Osteoarthritis |
125227671 | 12522767 | 6 | Parkinson's disease |
125227671 | 12522767 | 7 | Osteoarthritis |
125227671 | 12522767 | 8 | Insomnia |
125227671 | 12522767 | 9 | Parkinson's disease |
125227671 | 12522767 | 10 | Osteoporosis |
125227671 | 12522767 | 11 | Macular degeneration |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125227671 | 12522767 | LT |
125227671 | 12522767 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125227671 | 12522767 | Delusion | |
125227671 | 12522767 | Dyskinesia | |
125227671 | 12522767 | Hallucination, visual | |
125227671 | 12522767 | Hyperhidrosis | |
125227671 | 12522767 | Hyperkalaemia | |
125227671 | 12522767 | Hypertension | |
125227671 | 12522767 | Psychotic disorder | |
125227671 | 12522767 | Pyrexia | |
125227671 | 12522767 | Renal failure | |
125227671 | 12522767 | Rhabdomyolysis | |
125227671 | 12522767 | Tachycardia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125227671 | 12522767 | 1 | 200811 | 20100403 | 0 | |
125227671 | 12522767 | 3 | 201001 | 20100401 | 0 | |
125227671 | 12522767 | 4 | 200901 | 20100403 | 0 | |
125227671 | 12522767 | 5 | 20100402 | 0 | ||
125227671 | 12522767 | 6 | 201001 | 20100403 | 0 | |
125227671 | 12522767 | 7 | 201002 | 20100403 | 0 | |
125227671 | 12522767 | 8 | 200811 | 20100403 | 0 | |
125227671 | 12522767 | 10 | 200811 | 0 |